Hills Bank & Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,175
Closed -$740K 225
2020
Q1
$740K Sell
4,175
-2,207
-35% -$416K 0.22% 75
2019
Q4
$1.22M Sell
6,382
-777
-11% -$140K 0.29% 70
2019
Q3
$1.21M Sell
7,159
-742
-9% -$121K 0.3% 69
2019
Q2
$1.32M Sell
7,901
-481
-6% -$66.6K 0.34% 66
2019
Q1
$1.23M Buy
8,382
+271
+3% +$39.3K 0.33% 66
2018
Q4
$1.08M Buy
+8,111
New +$1.33M 0.34% 66
2017
Q4
Sell
-7,779
Closed -$1.59M 136
2017
Q3
$1.59M Buy
7,779
+419
+6% +$97.4K 0.5% 47
2017
Q2
$1.79M Buy
7,360
+285
+4% +$67K 0.58% 39
2017
Q1
$1.69M Buy
7,075
+469
+7% +$109K 0.57% 41
2016
Q4
$1.39M Buy
6,606
+585
+10% +$121K 0.49% 48
2016
Q3
$1.39M Buy
6,021
+1,505
+33% +$368K 0.5% 49
2016
Q2
$1.04M Buy
+4,516
New +$1.04M 0.38% 61

Other funds holding AGN

Hills Bank & Trust's AGN Position: Q2 2020 in Review

Hills Bank & Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,175 shares — an estimated $740K sold.

Hills Bank & Trust first reported a position in AGN in Q2 2016 and held it in 12 quarters. The position peaked at $1.79M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Hills Bank & Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Hills Bank & Trust sold 4,175 Allergan plc shares in Q2 2020, an estimated $740K.
  • Hills Bank & Trust first reported a position in Allergan plc in Q2 2016 and held it in 12 quarters.
  • Hills Bank & Trust's Allergan plc position peaked at $1.79M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Hills Bank & Trust's 13F filing for Q2 2020, filed 5 Aug 2020.